Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly
Public ClinicalTrials.gov record NCT00765323. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III, Open-Label, Multicenter International Study to Evaluate the Efficacy and Safety of an Octreotide Implant vs. Sandostatin LAR Depot in Patients With Acromegaly
Study identification
- NCT ID
- NCT00765323
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Industry
- Enrollment
- 169 participants
Conditions and interventions
Conditions
Interventions
- Octreotide Implant Drug
- Sandostatin LAR Depot Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2008
- Primary completion
- Jan 31, 2011
- Completion
- May 31, 2011
- Last update posted
- Sep 26, 2013
2008 – 2011
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford University Medical Center - Stanford Hospitals and Clinics | Palo Alto | California | 94304 | — |
| University of Colorado - Veterans Administration Medical Center - Endocrinology | Denver | Colorado | 80220 | — |
| Galiz Research | Miami | Florida | 33145 | — |
| The University of Illinois at Chicago | Chicago | Illinois | 60608 | — |
| Sinai Hospital of Baltimore, Medicine - Div. of Endocrinology and Metabolism | Baltimore | Maryland | 21215 | — |
| The Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Oregon Health and Science University, Endocrinology | Portland | Oregon | 97239 | — |
| Seattle Neuroscience Institute - Swedish Medical Center | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00765323, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 26, 2013 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00765323 live on ClinicalTrials.gov.